Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Fitzpatrick

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Critical Reviews in Oncology/Hematology|October 20, 2009
Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adultsJean-Pierre Droz, Lodovico Balducci, Michel Bolla, et al.
Kidney International|November 25, 2003
DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transitionDebra F Higgins, David W P Lappin, Niamh E Kieran, et al.
Molecular Cancer|October 11, 2011
Characterisation and manipulation of docetaxel resistant prostate cancer cell linesAmanda J O'Neill, Maria Prencipe, Catherine Dowling, et al.
Cancer Biology & Therapy|December 25, 2008
The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkersRuth Foley, Laure Marignol, Arun Z Thomas, et al.
The Prostate|July 21, 2017
Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgeryKieran J Breen, Amanda O'Neill, Lisa Murphy, et al.
The Lancet. Oncology|August 1, 2014
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric OncologyJean-Pierre Droz, Matti Aapro, Lodovico Balducci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalizationEmma M Gallagher, Deirdre M O'Shea, Patricia Fitzpatrick, et al.
Critical Reviews in Oncology/Hematology|August 30, 2008
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approachJohn M Fitzpatrick, John Anderson, Cora N Sternberg, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2014
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus PanelJohn M Fitzpatrick, Joaquim Bellmunt, Karim Fizazi, et al.
European Urology|September 20, 2014
Defining a standard set of patient-centered outcomes for men with localized prostate cancerNeil E Martin, Laura Massey, Caleb Stowell, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Critical Reviews in Oncology/Hematology|October 20, 2009
Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adultsJean-Pierre Droz, Lodovico Balducci, Michel Bolla, et al.
Kidney International|November 25, 2003
DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transitionDebra F Higgins, David W P Lappin, Niamh E Kieran, et al.
Molecular Cancer|October 11, 2011
Characterisation and manipulation of docetaxel resistant prostate cancer cell linesAmanda J O'Neill, Maria Prencipe, Catherine Dowling, et al.
Cancer Biology & Therapy|December 25, 2008
The HIF-1alpha C1772T polymorphism may be associated with susceptibility to clinically localised prostate cancer but not with elevated expression of hypoxic biomarkersRuth Foley, Laure Marignol, Arun Z Thomas, et al.
The Prostate|July 21, 2017
Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgeryKieran J Breen, Amanda O'Neill, Lisa Murphy, et al.
The Lancet. Oncology|August 1, 2014
Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric OncologyJean-Pierre Droz, Matti Aapro, Lodovico Balducci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalizationEmma M Gallagher, Deirdre M O'Shea, Patricia Fitzpatrick, et al.
Critical Reviews in Oncology/Hematology|August 30, 2008
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approachJohn M Fitzpatrick, John Anderson, Cora N Sternberg, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2014
Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus PanelJohn M Fitzpatrick, Joaquim Bellmunt, Karim Fizazi, et al.
European Urology|September 20, 2014
Defining a standard set of patient-centered outcomes for men with localized prostate cancerNeil E Martin, Laura Massey, Caleb Stowell, et al.
Pageof 18